Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04797988
Other study ID # D0000000160
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 6, 2021
Est. completion date May 15, 2021

Study information

Verified date June 2021
Source Dominion Aesthetic Technologies, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to provide objective evidence regarding the safety of eon® treatment of the flanks.


Description:

This study is designed to provide objective evidence regarding the safety of eon® treatment of the flanks.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date May 15, 2021
Est. primary completion date May 15, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Subject is a healthy male or female > 18 years or older seeking treatment for unwanted fat in the flanks. - Subject must be able to read, understand and sign the Informed Consent Form (ICF) in English. - Subject has sufficient thickness (= 20 mm) of adipose tissue on the flanks area. - Subject must be willing and able to adhere to the treatment and follow-up visit schedule. - Subject is willing to have photographs and ultrasound measurements taken of the treated area. - Female subjects must be using medically acceptable form of birth control during the entire course of the study or may be post-menopausal, or surgically sterilized. Exclusion Criteria: - • Subject had an aesthetic fat reduction procedure in the treatment area within the previous year - Subject was pregnant in the last 3 months, intending to become pregnant, postpartum or nursing in last 6 months - Subject has an infection, dermatitis or a rash in the treatment area. - Subject has tattoos or jewelry in the treatment area or within the treatment area site or photography frame. - Subject has a history of keloid scarring, hypertrophic scarring or of abnormal wound healing. - Subject has a history of immunosuppression/immune deficiency disorders or currently using immunosuppressive medications. - Subject has a history of a known bleeding disorder. - Subject has a known photosensitivity to the study laser wavelength, history of ingesting medications known to induce photosensitivity, or history of seizure disorders due to light. - Subject has known collagen, vascular disease or scleroderma. - Subject has undergone a surgery or procedure in the treatment area within 6 months of treatment, which is still healing. - Subject suffers from significant concurrent illness, such as insulin-dependent diabetes, peripheral vascular disease or peripheral neuropathy. - Subject is undergoing systemic chemotherapy for the treatment of cancer. - Subject is using gold therapy for disorders such as rheumatologic disease or lupus. - Subject has participated in a study of another device or drug within three months prior to enrollment or during the study. - As per the investigator's discretion, the subject has any physical or mental condition which might make it unsafe for the subject to participate in this study. - Subject has ongoing use of steroids or secondary rheumatoid drugs. - Subject is actively taking psychotropic medications.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
eon® FR 1064 nm device
The subject will be treatment area - flanks, will be treated with the eon device.

Locations

Country Name City State
United States Fiala Aesthetics Altamonte Springs Florida

Sponsors (1)

Lead Sponsor Collaborator
Dominion Aesthetic Technologies, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Safety Evaluation eon® treatment of the flanks (Adverse Events) Adverse Events will be assessed to include ultrasound evaluations with a single expert sonographer identifying the pre-treatment versus Week 2 post-treatment. 2 weeks
Secondary Subject Satisfaction Subject Questionnaires will be completed by subjects at the end of the study to determine subject satisfaction with the procedure. Subjects will respond using a scale of 1-6, with 1 being extremely satisfied and 6 being extremely dissatisfied. 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT01345591 - A Study to Evaluate the Results of Facial Soft Tissue Reconstruction in Patients Who Have Suffered Traumatic Injury N/A
Recruiting NCT03675464 - Study of Human Adipose Tissue (LOSHAT)
Completed NCT03350997 - Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control N/A
Terminated NCT05128318 - TuLip : Role of the Tumor Environment in Cancer-related Fat Loss N/A
Recruiting NCT06169670 - Autologous Fat Grafting to the Face With Use of the Viality™ System N/A
Completed NCT03757767 - The Fasting Study - Unraveling the Mechanistic Effects of Prolonged Fasting in Humans. N/A
Completed NCT03314506 - Adipose Tissue Cellular Response to Exercise in Healthy Humans N/A
Recruiting NCT01605578 - Description of Abdominal and Gluteo-femoral Subcutaneous Adipose Tissue Cell Population in Women - GLUTAB N/A
Completed NCT04679246 - Participatory Intervention to Improve Nutrition and Physical Activity in Schoolchildren From Acatlán de Juárez, Jalisco N/A
Recruiting NCT05766566 - Treatment of Perianal Fistulas in Crohn's Disease With Autologous Microfragmented Adipose Tissue With the Lipogems System
Recruiting NCT04352244 - The Physiology of Human Brown Adipose Tissue
Recruiting NCT06304506 - Effect of Obesity on Extracellular Matrix Composition N/A
Completed NCT04834609 - Adipose Derived Mesenchymal Stem Cell Characteristics in Anal Fistulas N/A
Completed NCT00850629 - Hormonal Regulation of Body Weight Maintenance N/A
Terminated NCT03396978 - The Influence of Gonadal Hormone Suppression on Adipocyte Lineage and the Microbiome N/A
Active, not recruiting NCT06431230 - School-based HIIT and Dose-Response Effects N/A
Completed NCT02569112 - Evaluation of CoolSculpt Combining Venus Legacy Technology for Enhanced Results in Fat Reduction & Laxity of the Flanks N/A
Completed NCT01822301 - Structural Fat Grafting for Craniofacial Trauma: Repeat Fat Grafting Injection-5 Subject Cohort N/A
Recruiting NCT00809029 - The Influence Of GIP (Glucose-Dependent Insulinotropic Polypeptide) Infusion On Human Adipose Tissue: An In Vivo Study N/A
Terminated NCT01564524 - Effect of Concentrating Endogenous Stromal Cells in the Fat Graft N/A